BR100 Increased By (0.91%)
BR30 Increased By (1.13%)
KSE100 Increased By (0.9%)
KSE30 Increased By (1%)
AGHA 6.49 Increased By ▲ 0.11 (1.72%)
BECO 4.39 Increased By ▲ 0.04 (0.92%)
BML 62.30 Decreased By ▼ -0.25 (-0.4%)
BOP 31.49 Increased By ▲ 0.10 (0.32%)
CNERGY 11.86 Increased By ▲ 0.13 (1.11%)
CSIL 5.86 Decreased By ▼ -0.05 (-0.85%)
FCCL 62.35 Increased By ▲ 0.64 (1.04%)
FFL 14.95 Increased By ▲ 0.16 (1.08%)
FNEL 1.31 Increased By ▲ 0.07 (5.65%)
KEL 6.35 Increased By ▲ 0.03 (0.47%)
KOSM 5.86 Decreased By ▼ -0.04 (-0.68%)
LOTCHEM 24.72 Increased By ▲ 0.03 (0.12%)
MLCF 106.40 Increased By ▲ 2.47 (2.38%)
NBP 174.41 Increased By ▲ 1.09 (0.63%)
NCPL 52.21 Increased By ▲ 0.38 (0.73%)
NPL 55.00 Increased By ▲ 0.97 (1.8%)
OGDC 319.75 Increased By ▲ 3.88 (1.23%)
PACE 9.33 Increased By ▲ 0.07 (0.76%)
PAEL 35.93 Increased By ▲ 0.35 (0.98%)
PIBTL 13.90 Increased By ▲ 0.24 (1.76%)
PPL 228.61 Increased By ▲ 2.54 (1.12%)
PRL 81.70 Increased By ▲ 1.42 (1.77%)
PTC 47.15 Increased By ▲ 0.51 (1.09%)
SSGC 24.05 Increased By ▲ 0.23 (0.97%)
TBL 9.25 Increased By ▲ 0.01 (0.11%)
TELE 7.54 Decreased By ▼ -0.01 (-0.13%)
TPL 25.00 Increased By ▲ 0.46 (1.87%)
TPLP 13.15 Increased By ▲ 0.16 (1.23%)
TREET 26.03 Increased By ▲ 0.05 (0.19%)
TRG 53.80 Increased By ▲ 0.47 (0.88%)
World

Sweden to resume AstraZeneca jabs for over 65s

  • The vaccine is of great use for the elderly, among whom many fall seriously ill each day.
  • "At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."
Published Updated

STOCKHOLM: Sweden will resume use of AstraZeneca's COVID-19 vaccine for people aged 65 and older, the health agency said on Thursday, but keep the pause in place for younger Swedes as it continues to investigate a potential link between the shots and rare cases of blood clots.

"The vaccine is of great use for the elderly, among whom many fall seriously ill each day," Director General Johan Carlson said in a statement on the agency's new guidelines to the regional authorities administering the vaccinations in Sweden.

"At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."

Most countries which temporarily suspended the vaccine have now resumed administering shots following recommendations from the European Union's drug watchdog and the World Health Organization (WHO).

Both the European Medicines Agency (EMA) and the WHO said last week that the benefits of AstraZeneca's vaccine outweighed the risks.

Reuters

Comments

Comments are closed for this article.